Asante Solutions (PUMP) and NuVasive (NUVA) Critical Comparison

Asante Solutions (NASDAQ: PUMP) and NuVasive (NASDAQ:NUVA) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, earnings and institutional ownership.


This table compares Asante Solutions and NuVasive’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Asante Solutions -2,766.48% N/A -208.12%
NuVasive 6.36% 13.65% 6.17%

Valuation & Earnings

This table compares Asante Solutions and NuVasive’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Asante Solutions N/A N/A N/A N/A N/A
NuVasive $962.07 million 2.55 $37.14 million $1.19 40.51

NuVasive has higher revenue and earnings than Asante Solutions.

Analyst Recommendations

This is a summary of recent recommendations for Asante Solutions and NuVasive, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Asante Solutions 1 2 13 1 2.82
NuVasive 0 4 11 0 2.73

Asante Solutions presently has a consensus target price of $20.64, suggesting a potential upside of 25.72%. NuVasive has a consensus target price of $71.64, suggesting a potential upside of 48.61%. Given NuVasive’s higher probable upside, analysts clearly believe NuVasive is more favorable than Asante Solutions.


NuVasive beats Asante Solutions on 5 of the 8 factors compared between the two stocks.

Asante Solutions Company Profile

Asante Solutions, Inc. is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets. The Snap system also incorporates a technology that allows for auto-priming, whereby, without user intervention, the infusion tubing is automatically filled with insulin every time a new cartridge is inserted. The disposable pump body, which contains a fresh battery, is designed to be used for a week. The Company markets the Snap system through distributors of medical equipment and supplies to individuals with diabetes.

NuVasive Company Profile

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal product offering includes a minimally-disruptive surgical platform called Maximum Access Surgery (MAS). The platform includes its software-driven nerve detection and avoidance systems, including NVM5, and intraoperative monitoring services and support; MaXcess, an integrated split-blade retractor system, and a range of implants and biologics. The platform combines three product categories: its MaXcess retractors, specialized implants and fixation products, and nerve monitoring systems and service offerings that collectively enable surgeons to detect and navigate around nerves, while directing customized access to the spine for implant delivery.

Receive News & Ratings for Asante Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions and related companies with's FREE daily email newsletter.

Leave a Reply